Price T Rowe Associates Inc Immunocore Holdings PLC Put Options Transaction History
Price T Rowe Associates Inc
- $812 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IMCR
# of Institutions
124Shares Held
42MCall Options Held
110KPut Options Held
76.2K-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.05MShares$216 Million0.14% of portfolio
-
Wellington Management Group LLP Boston, MA6.13MShares$188 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$149 Million2.34% of portfolio
-
Primecap Management CO Pasadena, CA2.68MShares$82 Million0.07% of portfolio
-
Tang Capital Management LLC San Diego, CA1.56MShares$47.6 Million3.45% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.34B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...